Explore more publications!

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

Press releases published on October 27, 2025

Curia, 무균 API 제조 역량 강화 위해 400만 달러 투자
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia investiert 4 Mio. US-Dollar in die Optimierung der Herstellung steriler Wirkstoffe
Curia Melabur AS$4 Juta untuk Mempertingkat Pengeluaran API Steril
Curia investit 4 millions de dollars pour renforcer la fabrication stérile de substances actives (API)
Curia Investe US $4 Milhões para Aprimorar a Fabricação de APIs Estéreis
Curia ลงทุน 4 ล้านดอลลาร์เพื่อยกระดับการผลิต Sterile API
Curia 投資 400 萬美元增強無菌有效藥劑成分的製造
Curia משקיעה 4 מיליון דולר לשיפור ייצור API סטרילי
Curia Berinvestasi $4 Juta untuk Meningkatkan Mutu Manufaktur API Steril
Curia 投资 400 万美元改进无菌原料药(API)的制造
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer
Cannabix Technologies Granted Patent from USPTO for Contactless Breath Analysis
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Xenon to Report Q3 2025 Financial Results on November 3, 2025
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions